Ben Moree, PhD
Principal Scientist
Ben Moree is a Principal Scientist, Applications Development at Quantum-Si. His work at Quantum-Si has focused on the development of commercial applications and workflows for the next-generation protein sequencing technology. Prior to joining Quantum Si, Ben worked at BlueLight Therapeutics where he led drug discovery programs on difficult-to-drug oncology targets and helped develop the core technology platform. Ben received his PhD in Biochemistry from Stanford University where he studied chromatin epigenetics.
Latest Content
Online Event
Advances in Proteomics & Metabolomics 2023
This popular online event will once again bring together leading scientists in the field as they highlight the latest advancements in translational proteomics and metabolomics. Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.
Online Event
Advances in Proteomics & Metabolomics 2023
This popular online event will once again bring together leading scientists in the field as they highlight the latest advancements in translational proteomics and metabolomics. Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.
Advertisement
